Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome

Author:

Heitsch Laura12,Ibanez Laura3,Carrera Caty45,Binkley Michael M.1,Strbian Daniel6,Tatlisumak Turgut67ORCID,Bustamante Alejandro45,Ribó Marc5,Molina Carlos5,Dávalos Antoni8,López-Cancio Elena9ORCID,Muñoz-Narbona Lucia10ORCID,Soriano-Tárraga Carol10,Giralt-Steinhauer Eva1011,Obach Victor12,Slowik Agnieszka13,Pera Joanna13ORCID,Lapicka-Bodzioch Katarzyna14,Derbisz Justyna13,Sobrino Tomás1516,Castillo José15,Campos Francisco15,Rodríguez-Castro Emilio15,Arias-Rivas Susana15,Segura Tomas1516ORCID,Serrano-Heras Gemma16ORCID,Vives-Bauza Cristófol17,Díaz-Navarro Rosa17,Tur Silva17,Jimenez Carmen17,Martí-Fàbregas Joan18ORCID,Delgado-Mederos Raquel18,Arenillas Juan19ORCID,Krupinski Jerzy2021,Cullell Natalia2223,Torres-Aguila Nuria P.23ORCID,Muiño Elena2223ORCID,Cárcel-Márquez Jara2223,Moniche Francisco24ORCID,Cabezas Juan A.24ORCID,Ford Andria L.2ORCID,Dhar Rajat2ORCID,Roquer Jaume101125,Khatri Pooja26,Jiménez-Conde Jordi1011ORCID,Fernandez-Cadenas Israel42022ORCID,Montaner Joan427,Rosand Jonathan101125,Cruchaga Carlos3ORCID,Lee Jin-Moo2,

Affiliation:

1. Division of Emergency Medicine (L.H.), Washington University School of Medicine, St Louis, MO.

2. Department of Neurology (L.H., M.M.B., A.L.F., R.D., J.-M.L.), Washington University School of Medicine, St Louis, MO.

3. Department of Psychiatry (L.I., C. Cruchaga), Washington University School of Medicine, St Louis, MO.

4. Neurovascular Research Laboratory and Neurovascular Unit, Vall d’Hebron Institute of Research (VHIR) (C. Carrera, A.B., I.F.-C., J.M.), Universitat Autonoma de Barcelona, Spain.

5. Department of Neurology, Hospital Universitari Vall d”Hebron (C. Carrera, A.B., M.R., C.M.), Universitat Autonoma de Barcelona, Spain.

6. Department of Neurology, Helsinki University Hospital, Finland (D.S., T.T.).

7. Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg and Department of Neurology, Sahlgrenska University Hospital, Sweden (T.T.).

8. Department of Neurology, Hospital Universitari Germans Trias I Pujol, Badalona, Spain (A.D.).

9. Department of Neurology, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain (E.L.-C.).

10. Institut Hospital del Mar d’Investigacions Mediques (IMIM), Barcelona, Spain (L.M.-N., C.S.-T., E.G.-S., J.R., J.J.-C.).

11. Department of Neurology, Hospital de Mar, Barcelona, Spain (E.G.-S., J.R., J.J.-C.).

12. Department of Neuroscience, Hospital Clinic, University of Barcelona and August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain (V.O.).

13. Department of Neurology (A.S., J.P., J.D.), Jagiellonian University Medical College, Krakow, Poland.

14. Department of Neurogenetics (K.L.-B.), Jagiellonian University Medical College, Krakow, Poland.

15. Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela, Hospital Clinico Universitario, Universidade de Santiago de Compostela, Spain (T.S., J.C., F.C., E.R.-C., S.A.-R.).

16. Department of Neurology, Hospital Universitario de Albacete, Spain (T.S., G.S.-H.).

17. Department of Neurology, Son Espases University Hospital, IdISBa, Palma de Mallorca, Spain (C.V.-B., R.D.-N., S.T., C.J.).

18. Department of Neurology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain (J.M.-F., R.D.-M.).

19. Department of Neurology, Hospital Clinico Universitario de Valladolid, Spain (J.A.).

20. Department of Neurology, Hospital Mutua de Terrassa, Spain (J.K., I.F.-C.).

21. School of Life Sciences, Centre for Biosciences, Manchester Met University, United Kingdom (J.K.).

22. Stroke Pharmacogenomics and Genetics, Fundacio Docencia I Recerca Mutua de Terrassa, Spain (N.C., E.M., J.C.-M., I.F.-C.).

23. Stroke Pharmacogenomics and Genetics, Sant Pau Institute of Research, Sant Pau Hospital, Barcelona, Spain (N.C., N.P.T.-A., E.M., J.C.-M.).

24. Department of Neurology, Hospital Universitario Virgen del Rocio, Sevilla, Spain (F.M., J.A.C.).

25. Henry and Alison Center for Brain Health, Center for Genomic Medicine, Division of Neurocritical Care and Emergency Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (J.R.).

26. Department of Neurology, University of Cincinnati, OH (P.K.).

27. Institute de Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville and Department of Neurology, Hospital Universitario Virgen Macarena (J.M.).

Abstract

Background and Purpose: Large-scale observational studies of acute ischemic stroke (AIS) promise to reveal mechanisms underlying cerebral ischemia. However, meaningful quantitative phenotypes attainable in large patient populations are needed. We characterize a dynamic metric of AIS instability, defined by change in National Institutes of Health Stroke Scale score (NIHSS) from baseline to 24 hours baseline to 24 hours (NIHSS baseline – NIHSS 24hours = ΔNIHSS 6-24h ), to examine its relevance to AIS mechanisms and long-term outcomes. Methods: Patients with NIHSS prospectively recorded within 6 hours after onset and then 24 hours later were enrolled in the GENISIS study (Genetics of Early Neurological Instability After Ischemic Stroke). Stepwise linear regression determined variables that independently influenced ΔNIHSS 6 –24h . In a subcohort of tPA (alteplase)-treated patients with large vessel occlusion, the influence of early sustained recanalization and hemorrhagic transformation on ΔNIHSS 6–24h was examined. Finally, the association of ΔNIHSS 6 –24h with 90-day favorable outcomes (modified Rankin Scale score 0–2) was assessed. Independent analysis was performed using data from the 2 NINDS-tPA stroke trials (National Institute of Neurological Disorders and Stroke rt-PA). Results: For 2555 patients with AIS, median baseline NIHSS was 9 (interquartile range, 4–16), and median ΔNIHSS 6 –24h was 2 (interquartile range, 0–5). In a multivariable model, baseline NIHSS, tPA-treatment, age, glucose, site, and systolic blood pressure independently predicted ΔNIHSS 6 –24h (R 2 =0.15). In the large vessel occlusion subcohort, early sustained recanalization and hemorrhagic transformation increased the explained variance (R 2 =0.27), but much of the variance remained unexplained. ΔNIHSS 6 –24h had a significant and independent association with 90-day favorable outcome. For the subjects in the 2 NINDS-tPA trials, ΔNIHSS 3 –24h was similarly associated with 90-day outcomes. Conclusions: The dynamic phenotype, ΔNIHSS 6–24h , captures both explained and unexplained mechanisms involved in AIS and is significantly and independently associated with long-term outcomes. Thus, ΔNIHSS 6 –24h promises to be an easily obtainable and meaningful quantitative phenotype for large-scale genomic studies of AIS.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3